ABT vs EIX · P/E 25, rev $44.33B vs P/E 7.3, rev $17.60B
Abbott Laboratories (ABT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ABT and EIX stock pages for the full models.
Not investment advice.